Coagulopathy following bites by the Papuan taipan (Oxyuranus scutellatus canni)

Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
D G LallooDavid A Warrell

Abstract

The mechanisms of haemostatic failure were studied in 87 patients bitten by the Papuan taipan (Oxyuranus scutellatus canni). Eighty (92%) had evidence of a coagulopathy on laboratory testing; 36 (41.4%) developed spontaneous systemic bleeding, although this was rarely of clinical significance. Coagulation assays in 48 completely defibrinated patients showed marked reductions in factors V and VIII and reductions in factors II, IX, XI, XII and XIIIA. There was a reduction in plasminogen and alpha 2-antiplasmin levels and both total and cross-linked fibrin(ogen) degradation products (FDP) levels were elevated. The mean platelet count was initially decreased and fell further during admission. Similar but less severe changes were seen in patients who were mildly defibrinated. Following treatment with antivenom, fibrinogen levels rose rapidly and coagulability was restored within 6-12 h in 93% of patients. These abnormalities may be primarily attributable to the prothrombin activator present in taipan venom, but it is likely that other uncharacterized venom components contributed.

Citations

Jun 24, 2009·Intensive Care Medicine·Simon G A BrownGeoffrey K Isbister
Sep 21, 2001·British Journal of Haematology·I B SundellM Zuzel
Jul 3, 2009·QJM : Monthly Journal of the Association of Physicians·G K IsbisterUNKNOWN ASP Investigators
Jun 17, 2003·Journal of Toxicology. Clinical Toxicology·David G Lalloo, R David G Theakston
Jul 25, 2013·Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists·K MaduwageG K Isbister
Jan 30, 2010·Lancet·David A Warrell
Sep 29, 2009·Toxicology·Geoffrey K Isbister
Oct 4, 2008·Toxicon : Official Journal of the International Society on Toxinology·P P TanosS B Duffull
Mar 31, 2007·Pathology·Geoffrey K IsbisterUNKNOWN Australian Snakebite Project Investigators
Jul 21, 2007·Internal Medicine Journal·G K IsbisterB J Currie
Jan 10, 2014·CPT: Pharmacometrics & Systems Pharmacology·A GulatiS B Duffull
Jul 5, 2005·Toxicon : Official Journal of the International Society on Toxinology·Ronelle E Welton, James N Burnell
Nov 16, 2012·Toxicon : Official Journal of the International Society on Toxinology·Abhishek GulatiStephen B Duffull
Jun 12, 2009·Clinical Pharmacology and Therapeutics·T WajimaS B Duffull
Oct 24, 2014·PLoS Neglected Tropical Diseases·Kalana Maduwage, Geoffrey K Isbister
Jul 5, 2016·Toxicon : Official Journal of the International Society on Toxinology·Diego NavarroGuillermo León
Aug 27, 2014·The American Journal of Tropical Medicine and Hygiene·María HerreraJosé María Gutiérrez
Nov 13, 1999·Arteriosclerosis, Thrombosis, and Vascular Biology·V D ChouhanA K Rao

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.